基本信息
浏览量:0
职业迁徙
个人简介
His largest fields of interest are renal cell carcinoma, immunotherapy (cytokines, vaccines), and development of new strategies (antiangiogenic drugs, gene therapy). He has been largely involved in the development of new targeted therapies for RCC, and has been the PI of many trials in the field of RCC, from phase I to phase III.
He is a member of ASCO, AACR, ESMO, and has been the chair of the GU Group of ESMO from 2008 to 2010, and is currently the ESMO faculty coordinator for the GU group. He has published more than 290 papers in peer reviewed journals, mainly in the field of Renal Cancer.
He is a member of ASCO, AACR, ESMO, and has been the chair of the GU Group of ESMO from 2008 to 2010, and is currently the ESMO faculty coordinator for the GU group. He has published more than 290 papers in peer reviewed journals, mainly in the field of Renal Cancer.
研究兴趣
论文共 760 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of Clinical Oncologyno. 6_suppl (2023): 603-603
引用7浏览0引用
7
0
引用2浏览0引用
2
0
Manon de Vries-Brilland,Nathalie Rioux-Leclercq,Maxime Meylan, Jonathan Dauve, Christophe Passot, Elena Spirina-Menand,Ronan Flippot,Gaelle Fromont,Gwenaelle Gravis,Lionnel Geoffrois,Christine Chevreau,Frederic Rolland,
European urology oncology (2023)
引用0浏览0WOS引用
0
0
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn